TMB in NSCLC: A Broken Dream?

by Sara Bravaccini, Giuseppe Bronte, Paola Ulivi
Published 2021-06-01

Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the Future

by Fabio Nicolini, Martine Bocchini, Giuseppe Bronte, Angelo Delmonte, Massimo Guidoboni, Lucio Crinò, Massimiliano Mazza
Published 2020-01-01

Fully Human Antibodies for Malignant Pleural Mesothelioma Targeting

by Fabio Nicolini, Martine Bocchini, Davide Angeli, Giuseppe Bronte, Angelo Delmonte, Lucio Crinò, Massimiliano Mazza
Published 2020-04-01

Progress with palbociclib in breast cancer: latest evidence and clinical considerations

by Andrea Rocca, Alessio Schirone, Roberta Maltoni, Sara Bravaccini, Lorenzo Cecconetto, Alberto Farolfi, Giuseppe Bronte, Daniele Andreis
Published 2017-02-01

Hypoxia and Human Genome Stability: Downregulation of BRCA2 Expression in Breast Cancer Cell Lines

by Daniele Fanale, Viviana Bazan, Stefano Caruso, Marta Castiglia, Giuseppe Bronte, Christian Rolfo, Giuseppe Cicero, Antonio Russo
Published 2013-01-01

Advances in Molecular Mechanisms and Immunotherapy Involving the Immune Cell-Promoted Epithelial-to-Mesenchymal Transition in Lung Cancer

by Serena De Matteis, Matteo Canale, Alberto Verlicchi, Giuseppe Bronte, Angelo Delmonte, Lucio Crinò, Giovanni Martinelli, Paola Ulivi
Published 2019-01-01

Adjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step Forward

by Konstantinos Papadimitriou, Georgios Antoniou, Christian Rolfo, Antonio Russo, Giuseppe Bronte, Vassilios Vassiliou, Demetris Papamichael, Marc Peeters, Panteleimon Kountourakis
Published 2015-01-01

Case Report: Stevens-Johnson Syndrome and Hepatotoxicity Induced by Osimertinib Sequential to Pembrolizumab in a Patient With EGFR-Mutated Lung Adenocarcinoma

by Caterina Gianni, Giuseppe Bronte, Angelo Delmonte, Marco Angelo Burgio, Kalliopi Andrikou, Manlio Monti, Cecilia Menna, Giovanni Luca Frassineti, Lucio Crinò
Published 2021-08-01

Nintedanib in NSCLC: evidence to date and place in therapy

by Giuseppe Bronte, Francesco Passiglia, Antonio Galvano, Nadia Barraco, Angela Listì, Marta Castiglia, Sergio Rizzo, Eugenio Fiorentino, Viviana Bazan, Antonio Russo
Published 2016-05-01

Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer?

by Giuseppe Bronte, Andrea Rocca, Sara Ravaioli, Emanuela Scarpi, Massimiliano Bonafè, Maurizio Puccetti, Roberta Maltoni, Daniele Andreis, Giovanni Martinelli, Sara Bravaccini
Published 2019-01-01

The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer

by Giuseppe Bronte, Maurizio Puccetti, Elisabetta Petracci, Lorenza Landi, Paola Cravero, Simona Scodes, Paola Ulivi, Sara Ravaioli, Maria Maddalena Tumedei, Marco Angelo Burgio, Federico Cappuzzo, Angelo Delmonte, Lucio Crinò, Sara Bravaccini
Published 2021-05-01

Case Report: Circulating Myeloid-Derived Suppressive-Like Cells and Exhausted Immune Cells in Non-Small Cell Lung Cancer Patients Treated With Three Immune Checkpoint Inhibitors

by Giuseppe Bronte, Alberto Verlicchi, Serena De Matteis, Serena De Matteis, Alice Rossi, Alessandra Affatato, Francesco Giulio Sullo, Caterina Gianni, Matteo Canale, Marco Angelo Burgio, Angelo Delmonte, Michele Milella, Lucio Crinò
Published 2021-05-01

Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-B...

by Bruno Vincenzi, Massimo Di Maio, Marianna Silletta, Loretta D'Onofrio, Chiara Spoto, Maria Carmela Piccirillo, Gennaro Daniele, Francesca Comito, Eliana Maci, Giuseppe Bronte, Antonio Russo, Daniele Santini, Francesco Perrone, Giuseppe Tonini
Published 2015-01-01

Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases?

by Giuseppe Bronte, Sara Bravaccini, Sara Ravaioli, Maurizio Puccetti, Emanuela Scarpi, Daniele Andreis, Maria Maddalena Tumedei, Samanta Sarti, Lorenzo Cecconetto, Elisabetta Pietri, Valeria De Simone, Roberta Maltoni, Massimiliano Bonafè, Dino Amadori, Andrea Rocca
Published 2018-08-01

Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy?

by Giuseppe Bronte, Andrea Rocca, Sara Ravaioli, Maurizio Puccetti, Maria Maddalena Tumedei, Emanuela Scarpi, Daniele Andreis, Roberta Maltoni, Samanta Sarti, Lorenzo Cecconetto, Anna Fedeli, Elisabetta Pietri, Valeria De Simone, Silvia Asioli, Dino Amadori, Sara Bravaccini
Published 2018-03-01

Are There Differences in Androgen Receptor Expression in Invasive Breast Cancer in African (Tanzanian) Population in Comparison With the Caucasian (Italian) Population?

by Sara Bravaccini, Sara Ravaioli, Dino Amadori, Emanuela Scarpi, Maurizio Puccetti, Andrea Rocca, Maria Maddalena Tumedei, Nestory Masalu, Jackson Kahima, Akwilina Pangan, Lucas Faustine, Alberto Farolfi, Roberta Maltoni, Massimiliano Bonafè, Massimiliano Bonafè, Patrizia Serra, Giuseppe Bronte
Published 2018-03-01

The impact of progesterone receptor expression on prognosis of patients with rapidly proliferating, hormone receptor-positive early breast cancer: a analysis of the IBIS 3 trial

by Sara Bravaccini, Giuseppe Bronte, Emanuela Scarpi, Sara Ravaioli, Roberta Maltoni, Anita Mangia, Maria Maddalena Tumedei, Maurizio Puccetti, Patrizia Serra, Lorenzo Gianni, Laura Amaducci, Nicoletta Biglia, Valentina Bounous, Angelo Virgilio Paradiso, Rosella Silvestrini, Dino Amadori, Andrea Rocca
Published 2020-02-01

Concomitant <i>TP53</i> Mutation Confers Worse Prognosis in <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer Patients Treated with TKIs

by Matteo Canale, Elisabetta Petracci, Angelo Delmonte, Giuseppe Bronte, Elisa Chiadini, Vienna Ludovini, Alessandra Dubini, Maximilian Papi, Sara Baglivo, Nicoletta De Luigi, Alberto Verlicchi, Rita Chiari, Lorenza Landi, Giulio Metro, Marco Angelo Burgio, Lucio Crinò, Paola Ulivi
Published 2020-04-01

Stabilizing versus Destabilizing the Microtubules: A Double-Edge Sword for an Effective Cancer Treatment Option?

by Daniele Fanale, Giuseppe Bronte, Francesco Passiglia, Valentina Calò, Marta Castiglia, Florinda Di Piazza, Nadia Barraco, Antonina Cangemi, Maria Teresa Catarella, Lavinia Insalaco, Angela Listì, Rossella Maragliano, Daniela Massihnia, Alessandro Perez, Francesca Toia, Giuseppe Cicero, Viviana Bazan
Published 2015-01-01